IP68-23: NCCN Risk Groups Do Not Predict Adverse Pathology or Oncologic Outcomes Among Patients with Grade Group 1 Prostate Cancer Undergoing Radical Prostatectomy in the Contemporary MRI Era

IP68-23: NCCN Risk Groups Do Not Predict Adverse Pathology or Oncologic Outcomes Among Patients with Grade Group 1 Prostate Cancer Undergoing Radical Prostatectomy in the Contemporary MRI Era

Sunday, May 17, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
146A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!